Charles River Laboratories International, Inc. (CRL)
194.08
-0.77
(-0.40%)
USD |
NYSE |
Dec 11, 12:19
Charles River Laboratories International EPS Diluted (Quarterly): 1.101 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.121 |
| Eli Lilly & Co. | 6.211 |
| Insulet Corp. | 1.240 |
| Bio-Techne Corp. | 0.2442 |
| Moderna, Inc. | -0.5128 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 55.56M |
| Revenue (Quarterly) | 1.005B |
| Total Expenses (Quarterly) | 950.43M |
| Enterprise Value | 12.06B |
| Gross Profit Margin (Quarterly) | 32.32% |
| Profit Margin (Quarterly) | 5.53% |
| Earnings Yield | -0.80% |
| Operating Earnings Yield | 4.93% |
| Normalized Earnings Yield | 1.757 |